Scorpion sting study tests simpler antivenom dosing
NCT ID NCT06333834
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested two different ways of giving scorpion antivenom to adults who were stung. One group got a dose based on how severe their symptoms were, while the other group got the same dose for everyone. The goal was to see if the simpler approach works just as well at relieving symptoms. The trial involved 56 people and looked at how fast symptoms went away, side effects, and how much venom and antivenom was in the blood.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- scorpion antivenom
- What this could lead to
- If successful, this could show that a simpler, one-size-fits-all dose of antivenom works just as well as the current severity-based dosing, making treatment faster and easier.
- What could go wrong
- This is a small, completed Phase 2/3 trial with only 56 participants, so results may not apply broadly. The experimental dose may not be as effective in more severe cases.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CENTRUROIDES ENVENOMATION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Servicios Médicos Municipales de San Pedro Tlaquepaque.
Tlaquepaque, Jalisco, 45560, Mexico